Rockefeller statement calls for justice and inclusivity in the United States
Read the Office of the President’s message to the campus community.
New faculty member designs chemical probes to dissect and alter immune protein function
Ekaterina Vinogradova, an organic chemist, investigates the functions of immune proteins, with the goal of finding new targets for therapies. She will join Rockefeller as an assistant professor on January 1, 2021.
Researcher studying the dynamics of gene activity, cell by cell, joins Rockefeller faculty
Junyue Cao examines patterns of gene expression in order to better understand how cells differentiate into distinct types and how the body’s organs maintain stable populations of cells throughout life. He will move to Rockefeller as an assistant professor this summer.
Stavros Niarchos Foundation donates $3 million to Rockefeller COVID-19 research
The grant bolsters Rockefeller’s round-the-clock research initiatives related to COVID-19 and the SARS-CoV-2 virus that causes it.
The Rockefeller University releases statement concerning Knut Wittkowski
The opinions that have been expressed by Knut Wittkowski, discouraging social distancing in order to hasten the development of herd immunity to the novel coronavirus, do not represent the views of The Rockefeller University, its leadership, or its faculty.
Elaine Fuchs awarded 2020 Canada Gairdner International Award for Biomedical Science
Fuchs, a world leader in the study of skin biology, is being recognized for revealing the molecular mechanisms by which skin stem cells make and repair tissues.
Paul Muller wins 2020 Weintraub Graduate Student Award
Muller receives the honor for his examination of the interactions between neurons in the intestinal tract, known as enteric neurons, and intestinal macrophages, a kind of immune cell.
Rockefeller gets a new, more efficient boiler
With the aid of a mobile crane and a crew of around 20, a fully assembled Cleaver Brooks Fire Tube boiler was delivered into the university’s Power House. This winter, after months of work to plumb, wire, and test the machine, it was lit for the first time and began providing heat to Rockefeller buildings.
The Tri-Institutional Therapeutics Discovery Institute renews partnerships with Takeda and Bridge Medicines
The renewal allows Rockefeller faculty to continue transforming their discoveries into new medicines.
New BSL-3 lab to advance research on pathogens
Rockefeller researchers studying the tuberculosis bacterium now have access to a state-of-the-art biosafety level 3 laboratory on campus. The new facility is one of only a small handful in New York City.
